Efthymiadis Agathoklis, Bourlaki Marianthi, Bastounis Anastasios
Division of General Medicine, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, OX3 9DU UK.
Division of Acute General Medicine, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, OX3 9DU UK.
Diabetol Int. 2022 Jan 28;13(3):513-521. doi: 10.1007/s13340-021-00564-9. eCollection 2022 Jul.
Living with type 1 diabetes can be associated with significant psychological morbidity, poor glycaemic control, and increased risk for microvascular complications. This systematic review sought to investigate the effects of psychological interventions on depression, anxiety, diabetes-related distress, quality of life, and glycaemic control in people with type 1 diabetes.
Eight electronic databases were searched for published and unpublished randomised controlled trials. Screening, data extraction, and risk of bias assessment (using the Cochrane Collaboration tool for assessing risk of bias 2.0) were independently undertaken by two study authors. The results of the studies were meta-analysed, implementing a random-effects model. The Grading of Recommendations Assessment and Development and Evaluation (GRADE) system was used to determine the confidence in the effect estimates.
Twenty studies were identified. Non-significant standardised mean differences (SMD) were found for depression symptoms (SMD = - 0.17, 95% CI [- 0.41, 0.07], = 0.16) and diabetes-related distress (SMD = - 0.12, 95% CI [- 0.27, 0.04], = 0.13). Significant SMD was found for quality of life (SMD = 0.27, 95% CI [0.11, 0.42], = 0.0007). Significant mean difference (MD) was found for HbA1c (MD = - 0.26, 95% CI [- 0.51, - 0.01], = 0.04). Prespecified subgroup analysis for cognitive behaviour-based interventions showed significant improvement for HbA1c (MD = - 0.23, 95% CI [- 0.44, - 0.02], = 0.03).
Psychological interventions were found to significantly increase quality of life and promote glucose control in people with type 1 diabetes. Depending on their cost-effectiveness, psychological interventions could be incorporated in routine clinical practice for people with type 1 diabetes and concomitant psychological morbidity.
The online version contains supplementary material available at 10.1007/s13340-021-00564-9.
1型糖尿病患者的生活可能伴有显著的心理疾病、血糖控制不佳以及微血管并发症风险增加。本系统评价旨在研究心理干预对1型糖尿病患者的抑郁、焦虑、糖尿病相关困扰、生活质量和血糖控制的影响。
检索了八个电子数据库,以查找已发表和未发表的随机对照试验。两名研究作者独立进行筛选、数据提取和偏倚风险评估(使用Cochrane协作组评估偏倚风险工具2.0)。对研究结果进行荟萃分析,采用随机效应模型。使用推荐分级评估、制定和评价(GRADE)系统来确定效应估计值的可信度。
共纳入20项研究。抑郁症状(标准化均数差[SMD]= -0.17,95%置信区间[-0.41, 0.07],P = 0.16)和糖尿病相关困扰(SMD = -0.12,95%置信区间[-0.27, 0.04],P = 0.13)的标准化均数差无统计学意义。生活质量的标准化均数差有统计学意义(SMD = 0.27,95%置信区间[0.11, 0.42],P = 0.0007)。糖化血红蛋白的平均差有统计学意义(MD = -0.26,95%置信区间[-0.51, -0.01],P = 0.04)。基于认知行为的干预措施的预设亚组分析显示糖化血红蛋白有显著改善(MD = -0.23,95%置信区间[-0.44, -0.02],P = 0.03)。
发现心理干预可显著提高1型糖尿病患者的生活质量并促进血糖控制。根据其成本效益,心理干预可纳入1型糖尿病合并心理疾病患者的常规临床实践中。
在线版本包含可在10.1007/s13340-021-00564-9获取的补充材料。